PDL BioPharma Return On Tangible Equity 2010-2020 | PDLI
PDL BioPharma return on tangible equity from 2010 to 2020. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.